About Enhancer
Enhancer ID: |
E_01_0713 |
Species: |
human |
Position :
|
chr1:212562611-212564611 |
Biosample name: |
|
Experiment class :
|
High+Lowthroughput |
Enhancer type: |
Enhancer |
Disease: |
Inflammation |
Pubmed ID: |
29413899
|
Enhancer experiment: |
Protein isolation and immunoblotting,RNA isolation,RT-qPCR, Chromatin immunoprecipitation (ChIP) |
Enhancer experiment description: |
Collectively, the results document that ATF3 expression in normal and transformed human liver originates from the canonical promoter A that responds to multiple stress signals. |
About Target gene
Target gene : |
ATF3 |
Strong evidence: |
qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: |
RNA-Seq |
Target gene experiment description: |
Collectively, the results document that ATF3 expression in normal and transformed human liver originates from the canonical promoter A that responds to multiple stress signals. |
About TF
TF name : |
-- |
TF experiment: |
Protein isolation and immunoblotting,RNA isolation,RT-qPCR, Chromatin immunoprecipitation (ChIP) |
TF experiment description: |
Collectively, the results document that ATF3 expression in normal and transformed human liver originates from the canonical promoter A that responds to multiple stress signals. |
About Function
Enhancer function : |
Collectively, the results document that ATF3 expression in normal and transformed human liver originates from the canonical promoter A that responds to multiple stress signals. |
Enhancer function experiment: |
Immunohistochemical staining |
Enhancer function experiment description: |
Collectively, the results document that ATF3 expression in normal and transformed human liver originates from the canonical promoter A that responds to multiple stress signals. |
About SNP
Upstream Pathway Annotation of TF
GeneName |
Pathway Name |
Source |
Gene Number |
Enhancer associated network
The number on yellow line represents the distance between enhancer and
target gene
Expression of target genes for the
enhancer
Enhancer associated SNPs